David A. Gewirtz, Ph.D.
Massey Cancer Center research program membership
Department of Pharmacology and Toxicology,
School of Medicine
PhD, Icahn School of Medicine at Mount Sinai (1978)
My research focuses on the capacity of senolytic agents to sensitize tumor cells to chemotherapy and radiation and the mitigation of the toxicity of cancer chemotherapy.
Disease focus of research
Breast, Prostate, Head & neck, Respiratory/lung
Autophagy,Cancer therapy resistance,DNA damage,Radiotherapy,Senescence
Published research (during tenure as a Massey Cancer Center member)
Search In PubMed